F M Investments LLC Sells 10,051 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

F M Investments LLC trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 13.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 65,814 shares of the healthcare conglomerate’s stock after selling 10,051 shares during the period. UnitedHealth Group comprises approximately 1.2% of F M Investments LLC’s investment portfolio, making the stock its 15th biggest position. F M Investments LLC’s holdings in UnitedHealth Group were worth $33,293,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of UNH. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at $25,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $28,000. Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group in the fourth quarter worth approximately $30,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. Finally, Promus Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at $32,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $580.16 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market capitalization of $530.68 billion, a P/E ratio of 37.43, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The business has a fifty day simple moving average of $510.86 and a two-hundred day simple moving average of $541.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.83 earnings per share. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.45%. UnitedHealth Group’s payout ratio is 54.19%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on UNH. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Mizuho increased their price target on UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday. Piper Sandler lowered their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research note on Friday, January 10th. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty-one analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $630.35.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. 0.33% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.